Andrew Brown & Hagens Berman
14 shared events · Importance 9 · Last updated Sep 18, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Andrew Brown: Andrew Brown is a founding partner at Schall, Brown & Schwartz, involved in the class action. He is a key figure in the litigation.
Hagens Berman: Hagens Berman is investigating the claims and representing investors in the class action. The firm is seeking clients and may benefit from a settlement.
Jun 14, 2026 · 294 articles
Regulatory
Andrew Brown: Andrew Brown is a founding partner at Schall Brown & Schwartz LLP, involved in the case.
Hagens Berman: Hagens Berman is a law firm soliciting lead plaintiffs and investigating the case, representing investors.
Jul 13, 2026 · 198 articles
Regulatory
Andrew Brown: Andrew Brown is a founding partner at Schall, Brown & Schwartz and a contact for investors.
Hagens Berman: Hagens Berman is investigating and representing investors in the class action, focusing on whether Cogent misrepresented its wavelength backlog. The firm's participation adds to the legal pressure on Cogent.
Jul 23, 2026 · 301 articles
Regulatory
Andrew Brown: Schall, Brown & Schwartz partner representing investors in the Innventure class action.
Hagens Berman: Shareholder rights firm investigating whether Innventure misled investors about the DarkNX project viability.
Aug 19, 2026 · 164 articles
Regulatory
Andrew Brown: Andrew Brown is a founding partner of Schall Brown & Schwartz LLP and a contact for investors.
Hagens Berman: Hagens Berman is investigating the claims and urging investors to contact them. They are leading the investigation into the alleged securities fraud.
Jul 16, 2026 · 299 articles
Regulatory
Andrew Brown: Partner at Schall, Brown & Schwartz.
Hagens Berman: Law firm that filed class action; represents investors seeking recovery.
Jul 21, 2026 · 217 articles
Regulatory
Andrew Brown: Founding partner of Schall Brown & Schwartz listed on the firm's Cogent case contact information.
Hagens Berman: Plaintiff firm investigating whether Cogent management intentionally misrepresented wavelength backlog and demand, and notifying investors of the deadline.
Jul 27, 2026 · 137 articles
Regulatory
Andrew Brown: Partner at Schall, Brown & Schwartz involved in the lawsuit.
Hagens Berman: Filed a class action lawsuit against Capricor.
Jul 27, 2026 · 305 articles
Regulatory
Andrew Brown: Andrew Brown is a founding partner of Schall Brown & Schwartz LLP and is involved in the class action as counsel for investors.
Hagens Berman: This law firm is conducting an investigation into Embecta's alleged securities law violations and encourages investors to submit losses. It is one of the firms seeking to represent the class.
Jul 01, 2026 · 233 articles
Regulatory
Andrew Brown: Andrew Brown is a partner at Schall Brown & Schwartz and is a contact for investors. He is not a direct party to the litigation.
Hagens Berman: Hagens Berman is a plaintiff law firm that has filed or is investigating the class action. It is actively encouraging investors to contact the firm.
Jul 06, 2026 · 310 articles
Regulatory
Andrew Brown: Andrew Brown, founding partner of Schall Brown & Schwartz, is a contact for investors regarding the Wix class action.
Hagens Berman: Hagens Berman is investigating claims that Wix violated federal securities laws and urges investors with significant losses to contact the firm.
Aug 03, 2026 · 113 articles
Regulatory
Andrew Brown: Founding partner of Schall, Brown & Schwartz associated with the UWM class action.
Hagens Berman: Firm investigating the alleged claims and soliciting UWM investors with substantial losses.
Aug 10, 2026 · 312 articles
Regulatory
Andrew Brown: Partner at Schall Brown & Schwartz LLP.
Hagens Berman: This law firm is investigating the claims and encouraging investors with substantial losses to contact them before the deadline.
Jul 29, 2026 · 126 articles
Regulatory
Andrew Brown: Founding partner of Schall, Brown & Schwartz, involved in investor notices.
Hagens Berman: The firm notified investors of the September 28, 2026 deadline and highlighted the FDA's extension of the BLA review period.
Aug 10, 2026 · 267 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Andrew Brown and Hagens Berman interact across events, view sentiment trends, and discover connected entities.
Open Dashboard